Journal of Clinical Trials
Open Access
ISSN: 2167-0870
ISSN: 2167-0870
Department of Cardiovascular Medicine, Shinshu University School of Medicine, Nagano, Japan
Research Article
Safety and Efficacy of a Single 48-mm Everolimus-Eluting Stent in Percutaneous Coronary Intervention for Diffuse Coronary Lesions: A Propensity Score Analysis
Author(s): Daisuke Sunohara*, Takashi Miura, Fumika Nomoto, Tadashi Itagaki, Toshinori Komatsu, Tomoaki Mochidome, Toshio Kasai and Uichi Ikeda
Objective: Percutaneous Coronary Intervention (PCI) for diffuse coronary lesions is challenging because it is difficult to cover all lesions with one stent. Until now, overlapping stents were used to treat diffuse coronary lesions. However, they carry a higher risk of stent thrombosis. In recent years, 48-mm everolimus-eluting stents, which are longer than the conventional stents, have become available, but their safety and efficacy have not yet been established. The aim of this study was to compare the clinical results of a single 48-mm everolimus-eluting stent with those of overlapping stents.
Methods: Between June 2018 and September 2020, 130 consecutive patients with 139 lesions underwent PCI with a single 48-mm everolimus-eluting stent (48S group) or ≥2 Overlapping Stents (OS group). The primary endpoints were adverse events (cardiac.. View More»
DOI:
10.35248/2167-0870.22.12.517